表紙
市場調査レポート

転移性肝臓癌:世界の治験レビュー

Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013

発行 GlobalData 商品コード 230752
出版日 ページ情報 英文 99 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
転移性肝臓癌:世界の治験レビュー Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013
出版日: 2013年12月30日 ページ情報: 英文 99 Pages
概要

当レポートでは、世界の転移性肝臓癌治療薬の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 転移性肝臓癌
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位国 − 中東およびアフリカ
    • 臨床試験に寄与している上位国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 臨床試験:相別
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:上位企業
      • AstraZeneca PLC
      • F. Hoffmann-La Roche Ltd.
      • Light Sciences Oncology, Inc.
      • Sirtex Medical Limited
      • NS Pharma, Inc.
      • Gradalis Inc.
      • Matrix Pharma (Canada) Inc.
      • Micromet AG
      • AVEO Pharmaceuticals, Inc.
      • Matrix Pharmaceutical Research
      • Provectus Pharmaceuticals, Inc.
      • Bayer AG
      • Pfizer Inc.
      • Merck & Co., Inc.
      • Biogen Idec Inc.
      • Celsion Corporation
      • Boston Scientific Corporation
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • The University of Texas M. D. Anderson Cancer Center
      • University Health Network
      • Radboud University
      • University of Pittsburgh
      • Massachusetts General Hospital
      • 京都大学
      • University of California, San Diego
      • University of Michigan Comprehensive Cancer Center
      • Samsung Medical Center
      • University of Heidelberg
      • Aarhus University
      • European Organization for Research and Treatment of Cancer
      • 関西医科大学
      • Cancer Prevention Institute of California
      • Sidney Kimmel Comprehensive Cancer Center
      • Dana-Farber Cancer Institute
      • Roswell Park Cancer Institute
      • Odense University Hospital
      • Royal Marsden Cancer Campaign
      • University of Michigan
  • 5件の主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1913CTIDB

GlobalData's clinical trial report, "Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Liver Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Metastatic Liver Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Metastatic Liver Cancer
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Metastatic Liver Cancer Therapeutics Clinical Trials
  • Prominent Drug Comparison
    • Clinical Trial Profiles
      • Clinical Trial Overview of Top Companies
      • Sirtex Medical Limited
      • Clinical Trial Overview of Sirtex Medical Limited
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Delcath Systems, Inc.
      • Clinical Trial Overview of Delcath Systems, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • PreScience Labs, LLC
      • Clinical Trial Overview of PreScience Labs, LLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • MediGene AG
      • Clinical Trial Overview of MediGene AG
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • AVEO Pharmaceuticals, Inc.
      • Clinical Trial Overview of AVEO Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • North Central Cancer Treatment Group
      • Clinical Trial Overview of North Central Cancer Treatment Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirtex Medical Limited, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Delcath Systems, Inc., 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PreScience Labs, LLC, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MediGene AG, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2013*

List of Figures

  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top